Abbott Labs Files Q2 2024 10-Q
Ticker: ABT · Form: 10-Q · Filed: 2024-07-31T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, healthcare
Related Tickers: ABT
TL;DR
**ABBOTT LABS 10-Q FILED: Q2 2024 financials are in, check performance.**
AI Summary
Abbott Laboratories filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter and first half of 2024, detailing financial performance and operational updates. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the pharmaceutical and medical device sectors.
Why It Matters
This filing provides investors with crucial financial data for Abbott Laboratories, enabling them to assess the company's performance and make informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing (10-Q) and does not inherently present new risks.
Key Players & Entities
- ABBOTT LABORATORIES (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 20240731 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended June 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on July 31, 2024.
What is the company's Standard Industrial Classification (SIC) code?
Abbott Laboratories' SIC code is 2834, for Pharmaceutical Preparations.
What is the company's primary business address?
The company's business address is 100 Abbott Park Road, Abbott Park, IL 60064-3500.
What is the SEC file number for Abbott Laboratories?
The SEC file number for Abbott Laboratories is 001-02189.
From the Filing
0001628280-24-033740.txt : 20240731 0001628280-24-033740.hdr.sgml : 20240731 20240731160217 ACCESSION NUMBER: 0001628280-24-033740 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240731 DATE AS OF CHANGE: 20240731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 241161823 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 10-Q 1 abt-20240630.htm 10-Q abt-20240630 0000001800 12-31 2024 Q2 false P12M 285 285 xbrli:shares iso4217:USD iso4217:USD xbrli:shares abt:segment xbrli:pure abt:intangibleAsset iso4217:JPY 0000001800 2024-01-01 2024-06-30 0000001800 exch:XCHI 2024-01-01 2024-06-30 0000001800 exch:XNYS 2024-01-01 2024-06-30 0000001800 2024-06-30 0000001800 2024-04-01 2024-06-30 0000001800 2023-04-01 2023-06-30 0000001800 2023-01-01 2023-06-30 0000001800 2023-12-31 0000001800 us-gaap:CommonStockMember 2024-03-31 0000001800 us-gaap:CommonStockMember 2023-03-31 0000001800 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000001800 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000001800 us-gaap:CommonStockMember 2024-06-30 0000001800 us-gaap:CommonStockMember 2023-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2024-03-31 0000001800 us-gaap:TreasuryStockCommonMember 2023-03-31 0000001800 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2024-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-06-30 0000001800 us-gaap:RetainedEarningsMember 2024-03-31 0000001800 us-gaap:RetainedEarningsMember 2023-03-31 0000001800 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000001800 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000001800 us-gaap:RetainedEarningsMember 2024-06-30 0000001800 us-gaap:RetainedEarningsMember 2023-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000001800 us-gaap:NoncontrollingInterestMember 2024-03-31 0000001800 us-gaap:NoncontrollingInterestMember 2023-03-31 0000001800 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0000001800 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0000001800 us-gaap:NoncontrollingInterestMember 2024-06-30 0000001800 us-gaap:NoncontrollingInterestMember 2023-06-30 0000001800 us-gaap:CommonStockMember 2023-12-31 0000001800 us-gaap:CommonStockMember 2022-12-31 0000001800 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0000001800 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2022-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-06-30 0000001800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0000001800 us-gaap:RetainedEarningsMember 2023-12-31 0000001800 us-gaap:RetainedEarningsMember 2022-12-31 0000001800 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0000001800 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 000000180